Feedback

Melanoma Drug Shows Promise

 

Researchers say the drug Keytruda has been able to extend the lives of patients with advanced melanoma. Three years after being treated, 40% of patients are still alive, compared to the usual survival rate of 5%. NBC's Erika Edwards reports.

Shows